Order Article Reprints

Pezzolo E, Ortoncelli M, Ferrucci SM, Guanti MB, Schena D, Napolitano M, Rossi M, Foti C, D’Amico D, Amoruso GF, et al. Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis. Journal of Clinical Medicine. 2024; 13(2):553. https://doi.org/10.3390/jcm13020553

Pezzolo, Elena, Michela Ortoncelli, Silvia Mariel Ferrucci, Mario Bruno Guanti, Donatella Schena, Maddalena Napolitano, Mariateresa Rossi, Caterina Foti, Domenico D’Amico, Giuseppe Fabrizio Amoruso, and et al. 2024. "Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis" Journal of Clinical Medicine 13, no. 2: 553. https://doi.org/10.3390/jcm13020553

Pezzolo, E., Ortoncelli, M., Ferrucci, S. M., Guanti, M. B., Schena, D., Napolitano, M., Rossi, M., Foti, C., D’Amico, D., Amoruso, G. F., Morrone, P., Ribero, S., Barei, F., Biagi, M., Pascucci, E., Patruno, C., Calzavara Pinton, P., Romita, P., Gargiulo, L., ... Naldi, L. (2024). Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis. Journal of Clinical Medicine, 13(2), 553. https://doi.org/10.3390/jcm13020553